Model for end‐stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standar

Hepatitis C virus reinfection in injection drug users

Jason Grebely, Brian Conway, Jesse D. Raffa, Calvin Lai, Mel Krajden, Mark W. Tyndall – 20 October 2006 – Spontaneous clearance of hepatitis C (HCV) may provide protection against reinfection. In a large community‐based cohort study of 3,553 inner‐city residents (mainly injection drug users), we identified HCV‐infected individuals in whom virological clearance had occurred and compared the rate of reinfection in this group with that observed in previously uninfected members of the same cohort.

Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent

Francesca Lodato, Maria Rosa Tamé, Marco Montagnani, Vittorio Sambri, Giovanna Liguori, Francesco Azzaroli, Paolo Costigliola, Gianluca Grazi, Enrico Roda, Giuseppe Mazzella – 20 October 2006 – The incidence of invasive fungal infection is increasing especially in the field of transplantation, affecting as many as 50% of bone marrow transplant (BMT) patients with neutropenia and 5‐20% of solid‐organ transplant (SOT) recipients. Fusarium species are soil saprophytes and plant pathogens.

Subscribe to